Inato

About:

Inato is a platform designed for clinical trials that can unlock research site potential.

Website: https://inato.com

Twitter/X: inatohealth

Top Investors: The Family, Cathay Innovation, Obvious Ventures, Serena, Kima Ventures

Description:

Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new therapies arrive to patients faster, and at lower prices

Total Funding Amount:

$35.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2016-01-01

Contact Email:

contact(AT)inato.com

Founders:

Jean-David Zeitoun, Kourosh Davarpanah, Philippe Ravaud, William Pambrun

Number of Employees:

51-100

Last Funding Date:

2023-03-29

IPO Status:

Private

© 2024 MyAiNote.com